Alpha Cognition Receives Japanese Patent for Alzheimer's Disease Drug Alpha-1062, Further Strengthening Patent Portfolio
Alpha Cognition, Inc. (“ACI”), a biotherapeutics drug developer with near term commercialization potential for its Alpha-1062 Alzheimer’s drug, is pleased to announce an additional patent was recently granted in Japan for the treatment of neurodegenerative diseases, further demonstrating the value…